Diadema Partners’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$969K	Buy	259,852 +203,754	+363%	+$760K	0.3%	29
2025 Q1	$155K	Buy	56,098 +5,728	+11%	+$15.8K	0.04%	41
2024 Q4	$279K	Buy	+50,370	New	+$279K	0.12%	44